Response to Immunotherapy in Cancer Patient One Biomarker is not Enough
Aref Zribi
Additional contact information
Aref Zribi: Sultan Qaboos Comprehensive Cancer Care and Research Centre, University Medical City, Oman
Biomedical Journal of Scientific & Technical Research, 2024, vol. 58, issue 1, 49971-49974
Abstract:
Immunotherapy have led to astronomic changes in cancer treatment with several approval by the Food and Drug Administration for varied cancers. In the era of precision oncology, medical oncologist needs biomarkers to guide their prescription of these new treatments, and to select the right patient for these high-cost drugs. in this article we describe the available predictors biomarkers for Immune checkpoint therapies response and their limitations.
Keywords: Journals on Medical Drug and Therapeutics; Journals on Emergency Medicine; Physical Medicine and Rehabilitation; Journals on Infectious Diseases Addiction Science and Clinical Pathology; Open Access Clinical and Medical Journal; Journals on Biomedical Science; List of Open Access Medical Journal; Journals on Biomedical Engineering; Open Access Medical Journal; Biomedical Science Articles; Journal of Scientific and Technical Research (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:
Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.009104.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.009104.php (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:58:y:2024:i:1:p:49971-49974
DOI: 10.26717/BJSTR.2024.58.009104
Access Statistics for this article
Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas
More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().